{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:55:34Z","timestamp":1785524134300,"version":"3.56.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Adipose tissue has been shown to play a key role in energy metabolism and it has been shown to regulate metabolic homeostasis through the secretion of adipokines. Neuregulin 4 (Nrg4), a novel adipokine secreted mainly by brown adipose tissue (BAT), has recently been characterized as having an important effect on the regulation of energy homeostasis and glucolipid metabolism. Nrg4 can modulate BAT-related thermogenesis by increasing sympathetic innervation of adipose tissue and therefore has potential metabolic benefits. Nrg4 improves metabolic dysregulation in various metabolic diseases such as insulin resistance, obesity, non-alcoholic fatty liver disease, and diabetes through several mechanisms such as anti-inflammation, autophagy regulation, pro-angiogenesis, and lipid metabolism normalization. However, inconsistent findings are found regarding the effects of Nrg4 on metabolic diseases in clinical settings, and this heterogeneity needs to be further clarified by future studies. The potential metabolic protective effect of Nrg4 suggests that it may be a promising endocrine therapeutic target.<\/jats:p>","DOI":"10.3389\/fphys.2022.1106380","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:31:52Z","timestamp":1673382712000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Neuregulin 4 as a novel adipokine in energy metabolism"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuanbin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction","volume":"18","author":"Achari","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.18176\/archmeddeporte.00066","article-title":"Comparison of the effects of 12 weeks of three types of resistance training (traditional, circular and interval) on the levels of neuregulin 4, adiponectin and leptin in non-athletic men with obesity","volume":"38","author":"Alizadeh","year":"2021","journal-title":"Arch. Med. Deporte"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1080\/01443615.2022.2054683","article-title":"Neuregulin 4 (NRG4) - the hormone with clinical significance in gestational diabetes mellitus","volume":"42","author":"Attique","year":"2022","journal-title":"J. Obstet. Gynaecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/aog.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: Implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39850","DOI":"10.1074\/jbc.M112.400846","article-title":"Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo","volume":"287","author":"Bernard","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrendo.2017.132","article-title":"Targeting thermogenesis in Brown fat and muscle to treat obesity and metabolic disease","volume":"14","author":"Betz","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12916-016-0703-6","article-title":"Association of circulating neuregulin 4 with metabolic syndrome in obese adults: A cross-sectional study","volume":"14","author":"Cai","year":"2016","journal-title":"BMC Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"BSR20211658","DOI":"10.1042\/bsr20211658","article-title":"Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome","volume":"41","author":"Cao","year":"2021","journal-title":"Biosci. Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/387512a0","article-title":"Neuregulin-2, a new ligand of ErbB3\/ErbB4-receptor tyrosine kinases","volume":"387","author":"Carraway","year":"1997","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cmet.2018.07.015","article-title":"CXCL14, a Brown adipokine that mediates Brown-Fat-to-Macrophage communication in thermogenic adaptation","volume":"28","author":"Cereijo","year":"2018","journal-title":"Cell Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11695-019-04104-y","article-title":"Elevated levels of circulating miR-92a are associated with impaired glucose homeostasis in patients with obesity and correlate with metabolic status after bariatric surgery","volume":"30","author":"Cereijo","year":"2020","journal-title":"Obes. Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2870","DOI":"10.1002\/dmrr.2870","article-title":"Elevated circulating Neuregulin4 level in patients with diabetes","volume":"33","author":"Chen","year":"2017","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.molmet.2017.03.016","article-title":"Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders","volume":"6","author":"Chen","year":"2017","journal-title":"Mol. Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.2147\/dmso.S376163","article-title":"New discovered adipokines associated with the pathogenesis of obesity and type 2 diabetes","volume":"15","author":"Cheng","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4161\/adip.29853","article-title":"Transcriptional fingerprinting of \"browning\" white fat identifies NRG4 as a novel adipokine","volume":"4","author":"Christian","year":"2015","journal-title":"Adipocyte"},{"key":"B19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fphys.2019.00039","article-title":"Neuregulin 4 is a novel marker of beige adipocyte precursor cells in human adipose tissue","volume":"10","author":"Comas","year":"2019","journal-title":"Front. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.metabol.2015.08.013","article-title":"A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease","volume":"64","author":"Dai","year":"2015","journal-title":"Metabolism"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0251822","DOI":"10.1371\/journal.pone.0251822","article-title":"Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?","volume":"16","author":"De Munck Tji","year":"2021","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1055\/a-1301-2378","article-title":"The role of Brown adipose tissue in the development and treatment of nonalcoholic steatohepatitis: An exploratory gene expression study in mice","volume":"52","author":"De Munck Tji","year":"2020","journal-title":"Horm. Metab. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"12960","DOI":"10.3390\/ijms222312960","article-title":"Neuregulin 4 downregulation induces insulin resistance in 3T3-L1 adipocytes through inflammation and autophagic degradation of GLUT4 vesicles","volume":"22","author":"D\u00edaz-S\u00e1ez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s0014-4827(02)00102-7","article-title":"Neuregulins: Functions, forms, and signaling strategies","volume":"284","author":"Falls","year":"2003","journal-title":"Exp. Cell Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.2174\/1871530321666210119115527","article-title":"Negative correlation between neuregulin-4 and IL-9 serum levels in patients with coronary artery disease","volume":"21","author":"Farshidi","year":"2021","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"B26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The m\u00e9nage \u00e0 trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3390\/biology11081237","article-title":"Adipokines in non-alcoholic fatty liver disease: Are we on the road toward new biomarkers and therapeutic targets?","volume":"11","author":"Francisco","year":"2022","journal-title":"Biol. (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2174\/0929867327666200824112056","article-title":"Obesity and insulin resistance: Associations with chronic inflammation, genetic and epigenetic factors","volume":"28","author":"Gasmi","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-021-09640-6","article-title":"The endocrine role of Brown adipose tissue: An update on actors and actions","volume":"23","author":"Gavald\u00e0-Navarro","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1042\/cs20200230","article-title":"Neuregulins: Protective and reparative growth factors in multiple forms of cardiovascular disease","volume":"134","author":"Geissler","year":"2020","journal-title":"Clin. Sci. (Lond)."},{"key":"B32","doi-asserted-by":"publisher","first-page":"667330","DOI":"10.3389\/fphys.2021.667330","article-title":"Adiposity measurements and metabolic syndrome are linked through circulating neuregulin 4 and adipsin levels in obese adults","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1172\/jci96324","article-title":"Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression","volume":"127","author":"Guo","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1038\/sj.onc.1202631","article-title":"Neuregulin-4: A novel growth factor that acts through the ErbB-4 receptor tyrosine kinase","volume":"18","author":"Harari","year":"1999","journal-title":"Oncogene"},{"key":"B35","doi-asserted-by":"publisher","first-page":"107998","DOI":"10.1016\/j.celrep.2020.107998","article-title":"Single-cell RNA profiling reveals adipocyte to macrophage signaling sufficient to enhance thermogenesis","volume":"32","author":"Henriques","year":"2020","journal-title":"Cell Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41586-020-2028-z","article-title":"\u03b3\u03b4 T cells and adipocyte IL-17RC control fat innervation and thermogenesis","volume":"578","author":"Hu","year":"2020","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1210\/en.2002-220382","article-title":"ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture","volume":"143","author":"Huotari","year":"2002","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"36710","DOI":"10.1038\/srep36710","article-title":"Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2016.04.007","article-title":"Comparison of serum Neuregulin 4 (Nrg4) levels in adults with newly diagnosed type 2 diabetes mellitus and controls without diabetes","volume":"117","author":"Kang","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B40","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: Metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1248\/bpb.b21-00988","article-title":"Nobiletin and 3'-demethyl nobiletin activate Brown adipocytes upon \u03b2-adrenergic stimulation","volume":"45","author":"Kihara-Negishi","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"B42","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/molecules27020334","article-title":"The roles and associated mechanisms of adipokines in development of metabolic syndrome","volume":"27","author":"Kim","year":"2022","journal-title":"Molecules"},{"key":"B43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","article-title":"Autophagy in metabolic disease and ageing","volume":"17","author":"Kitada","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e13206","DOI":"10.1111\/eci.13206","article-title":"Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus?","volume":"50","author":"Kocak","year":"2020","journal-title":"Eur. J. Clin. Invest."},{"key":"B45","doi-asserted-by":"publisher","first-page":"w20139","DOI":"10.4414\/smw.2019.20139","article-title":"Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus","volume":"149","author":"Kocak","year":"2019","journal-title":"Swiss Med. Wkly."},{"key":"B46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1530\/eje-19-0017","article-title":"The Brown fat-secreted adipokine neuregulin 4 is decreased in human and murine chronic kidney disease","volume":"181","author":"Kralisch","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diabet.2017.06.001","article-title":"The Brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus","volume":"44","author":"Kralisch","year":"2018","journal-title":"Diabetes Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/01443615.2019.1581754","article-title":"Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome","volume":"39","author":"Kurek Eken","year":"2019","journal-title":"J. Obstet. Gynaecol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/09513590.2017.1420772","article-title":"Clinical significance of neuregulin 4 (NRG4) in gestational diabetes mellitus","volume":"34","author":"Kurek Eken","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnsys.2015.00150","article-title":"Hypothalamic control of Brown adipose tissue thermogenesis","volume":"9","author":"Labb\u00e9","year":"2015","journal-title":"Front. Syst. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","author":"Lee","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1530\/ec-19-0175","article-title":"Elevated serum neuregulin 4 levels in patients with hyperthyroidism","volume":"8","author":"Li","year":"2019","journal-title":"Endocr. Connect."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2829662","DOI":"10.1155\/2022\/2829662","article-title":"Clinical significance of neuregulin 4, afamin, and SERPINB1 in gestational diabetes mellitus and their relationship with insulin resistance","volume":"2022","author":"Li","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2337\/db21-0064","article-title":"Mutations of NRG4 contribute to the pathogenesis of nonalcoholic fatty liver disease and related metabolic disorders","volume":"70","author":"Li","year":"2021","journal-title":"Diabetes"},{"key":"B55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/cvr\/cvab076","article-title":"Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis","volume":"118","author":"Liu","year":"2022","journal-title":"Cardiovasc Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"H1446","DOI":"10.1152\/ajpheart.00362.2012","article-title":"Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia","volume":"303","author":"Liu","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"26242","DOI":"10.1038\/srep26242","article-title":"Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"950791","DOI":"10.3389\/fphys.2022.950791","article-title":"Serum neuregulin 4 is negatively correlated with insulin sensitivity in humans and impairs mitochondrial respiration in HepG2 cells","volume":"13","author":"Mart\u00ednez","year":"2022","journal-title":"Front. Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"6613827","DOI":"10.1155\/2021\/6613827","article-title":"NAFLD, insulin resistance, and diabetes mellitus type 2","volume":"2021","author":"Maru\u0161i\u0107","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.ajpath.2014.06.015","article-title":"The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis","volume":"184","author":"McElroy","year":"2014","journal-title":"Am. J. Pathol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ecl.2021.05.006","article-title":"Ethnic disparities in diabetes","volume":"50","author":"Mikhail","year":"2021","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/ijms23042222","article-title":"Adipsin serum concentrations and adipose tissue expression in people with obesity and type 2 diabetes","volume":"23","author":"Milek","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bbrc.2018.06.043","article-title":"Neuregulin-4 is an angiogenic factor that is critically involved in the maintenance of adipose tissue vasculature","volume":"503","author":"Nugroho","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbrc.2018.08.197","article-title":"Activation of neuregulin-4 in adipocytes improves metabolic health by enhancing adipose tissue angiogenesis","volume":"504","author":"Nugroho","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1161\/circresaha.112.267286","article-title":"Neuregulin in cardiovascular development and disease","volume":"111","author":"Odiete","year":"2012","journal-title":"Circ. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2021.04.028","article-title":"Physical activity in management of persons with obesity","volume":"93","author":"Oppert","year":"2021","journal-title":"Eur. J. Intern Med."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0288-20.2021","article-title":"Neuregulin-4 is required for maintaining soma size of pyramidal neurons in the motor cortex","volume":"8","author":"Paramo","year":"2021","journal-title":"eNeuro"},{"key":"B69","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.expneurol.2018.01.002","article-title":"An essential role for neuregulin-4 in the growth and elaboration of developing neocortical pyramidal dendrites","volume":"302","author":"Paramo","year":"2018","journal-title":"Exp. Neurol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/jnen\/nlz046","article-title":"Neuregulin-4 is required for the growth and elaboration of striatal medium spiny neuron dendrites","volume":"78","author":"Paramo","year":"2019","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1038\/s41467-018-07453-x","article-title":"Adipocyte-secreted BMP8b mediates adrenergic-induced remodeling of the neuro-vascular network in adipose tissue","volume":"9","author":"Pellegrinelli","year":"2018","journal-title":"Nat. Commun."},{"key":"B72","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1038\/s41598-020-62680-x","article-title":"Clinical significance of serum concentrations of neuregulin-4, in acute coronary syndrome","volume":"10","author":"Rahimzadeh","year":"2020","journal-title":"Sci. Rep."},{"key":"B74","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/s2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"E945","DOI":"10.1152\/ajpendo.00473.2013","article-title":"Brown and white adipose tissues: Intrinsic differences in gene expression and response to cold exposure in mice","volume":"306","author":"Rosell","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B76","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the international diabetes federation diabetes atlas, 9th edition","volume":"9157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B77","doi-asserted-by":"publisher","first-page":"797574","DOI":"10.3389\/fphys.2021.797574","article-title":"Differential effects of exercise programs on neuregulin 4, body composition and cardiometabolic risk factors in men with obesity","volume":"12","author":"Saeidi","year":"2021","journal-title":"Front. Physiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000321319","article-title":"Brown versus white adipose tissue: A mini-review","volume":"58","author":"Saely","year":"2012","journal-title":"Gerontology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4239\/wjd.v12.i5.556","article-title":"Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes","volume":"12","author":"Sharma","year":"2021","journal-title":"World J. Diabetes"},{"key":"B82","first-page":"5501","article-title":"Neuregulin 4 attenuate tubulointerstitial fibrosis and advanced glycosylation end products accumulation in diabetic nephropathy rats via regulating TNF-R1 signaling","volume":"11","author":"Shi","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41398-020-00868-5","article-title":"Neuregulin 1: An intriguing therapeutic target for neurodevelopmental disorders","volume":"10","author":"Shi","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00223-021-00897-2","article-title":"Neuregulin 4 attenuates osteoarthritis progression by inhibiting inflammation and apoptosis of chondrocytes in mice","volume":"110","author":"Shi","year":"2022","journal-title":"Calcif. Tissue Int."},{"key":"B85","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5604\/01.3001.0010.8631","article-title":"Nonalcoholic fatty liver disease progresses into severe NASH when physiological mechanisms of tissue homeostasis collapse","volume":"17","author":"Sookoian","year":"2018","journal-title":"Ann. Hepatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1210\/en.2012-2133","article-title":"The neuregulin system of ligands and their receptors in rat islets of langerhans","volume":"154","author":"South","year":"2013","journal-title":"Endocrinology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"802541","DOI":"10.3389\/fendo.2021.802541","article-title":"The nuanced metabolic functions of endogenous FGF21 depend on the nature of the stimulus, tissue source, and experimental model","volume":"12","author":"Spann","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"595020","DOI":"10.3389\/fendo.2021.595020","article-title":"Signaling pathways regulating thermogenesis","volume":"12","author":"Tabuchi","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"B89","doi-asserted-by":"publisher","first-page":"517","DOI":"10.5603\/GP.a2017.0095","article-title":"Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study","volume":"88","author":"Temur","year":"2017","journal-title":"Ginekol. Pol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1536\/ihj.18-130","article-title":"Association of circulating neuregulin-4 with presence and severity of coronary artery disease","volume":"60","author":"Tian","year":"2019","journal-title":"Int. Heart J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"898139","DOI":"10.3389\/fendo.2022.898139","article-title":"Hypothalamic estrogen signaling and adipose tissue metabolism in energy homeostasis","volume":"13","author":"Torres Irizarry","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e14555","DOI":"10.1111\/ijcp.14555","article-title":"Serum neuregulin 4 (NRG-4) level and non-alcoholic fatty liver disease (NAFLD): A case-control study","volume":"75","author":"Tutunchi","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e12952","DOI":"10.1111\/obr.12952","article-title":"A systematic review of the association of neuregulin 4, a Brown fat-enriched secreted factor, with obesity and related metabolic disturbances","volume":"21","author":"Tutunchi","year":"2020","journal-title":"Obes. Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/joim.12803","article-title":"Inflammation of Brown\/beige adipose tissues in obesity and metabolic disease","volume":"284","author":"Villarroya","year":"2018","journal-title":"J. Intern Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrendo.2016.136","article-title":"Brown adipose tissue as a secretory organ","volume":"13","author":"Villarroya","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/joe-19-0295","article-title":"New insights into the secretory functions of Brown adipose tissue","volume":"243","author":"Villarroya","year":"2019","journal-title":"J. Endocrinol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/nm.3713","article-title":"The Brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/cells8121597","article-title":"The upstream pathway of mTOR-mediated autophagy in liver diseases","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"B99","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12933-022-01643-0","article-title":"Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK\/mTOR signalling pathway","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc Diabetol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.7150\/ijbs.75488","article-title":"Regulation of adipose thermogenesis and its critical role in glucose and lipid metabolism","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e12289","DOI":"10.1111\/cob.12289","article-title":"Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity","volume":"9","author":"Wang","year":"2019","journal-title":"Clin. Obes."},{"key":"B102","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/07435800.2020.1721528","article-title":"Differences in neuregulin 4 expression in children: Effects of fat depots and obese status","volume":"45","author":"Wang","year":"2020","journal-title":"Endocr. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrm.2016.96","article-title":"Control of Brown and beige fat development","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1535370219839643","article-title":"Feature Article: Transplantation of neuregulin 4-overexpressing adipose-derived mesenchymal stem cells ameliorates insulin resistance by attenuating hepatic steatosis","volume":"244","author":"Wang","year":"2019","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e0225705","DOI":"10.1371\/journal.pone.0225705","article-title":"Association between circulating neuregulin4 levels and diabetes mellitus: A meta-analysis of observational studies","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr. Rev."},{"key":"B107","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.1038\/s41598-017-06447-x","article-title":"Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice","volume":"7","author":"Weitkunat","year":"2017","journal-title":"Sci. Rep."},{"key":"B108","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2012.02.066","article-title":"BMP8B increases Brown adipose tissue thermogenesis through both central and peripheral actions","volume":"149","author":"Whittle","year":"2012","journal-title":"Cell"},{"key":"B109","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cell.2012.05.016","article-title":"Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human","volume":"150","author":"Wu","year":"2012","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"6974191","DOI":"10.1155\/2018\/6974191","article-title":"Plasma neuregulin 4 levels are associated with metabolic syndrome in patients newly diagnosed with type 2 diabetes mellitus","volume":"2018","author":"Yan","year":"2018","journal-title":"Dis. Markers"},{"key":"B111","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.cyto.2018.10.007","article-title":"Decreased plasma neuregulin 4 levels are associated with peripheral neuropathy in Chinese patients with newly diagnosed type 2 diabetes: A cross-sectional study","volume":"113","author":"Yan","year":"2019","journal-title":"Cytokine"},{"key":"B112","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13098-020-00550-2","article-title":"Changes of circulating neuregulin 4 and its relationship with 25-hydroxy vitamin D and other diabetic vascular complications in patients with diabetic peripheral neuropathy","volume":"12","author":"Yan","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00592-017-1044-4","article-title":"Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: A cross-sectional study","volume":"54","author":"Yan","year":"2017","journal-title":"Acta Diabetol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"108628","DOI":"10.1016\/j.jnutbio.2021.108628","article-title":"n-3 PUFAs protect against adiposity and fatty liver by promoting browning in postnatally overfed male rats: a role for NRG4","volume":"93","author":"Yang","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"B115","doi-asserted-by":"publisher","first-page":"E583","DOI":"10.1152\/ajpendo.00166.2018","article-title":"ErbB4 deletion predisposes to development of metabolic syndrome in mice","volume":"315","author":"Zeng","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-019-1156-9","article-title":"Innervation of thermogenic adipose tissue via a calsyntenin 3\u03b2-S100b axis","volume":"569","author":"Zeng","year":"2019","journal-title":"Nature"},{"key":"B117","doi-asserted-by":"publisher","first-page":"188707","DOI":"10.1016\/j.bbcan.2022.188707","article-title":"Oncogenic neuregulin 1 gene (NRG1) fusions in cancer: A potential new therapeutic opportunities","volume":"1877","author":"Zhang","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B118","doi-asserted-by":"publisher","first-page":"9562","DOI":"10.1073\/pnas.94.18.9562","article-title":"Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B119","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.lfs.2018.12.006","article-title":"Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice","volume":"217","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s12020-017-1324-3","article-title":"Circulating neuregulin 4 concentrations in patients with newly diagnosed type 2 diabetes: A cross-sectional study","volume":"57","author":"Zhang","year":"2017","journal-title":"Endocrine"},{"key":"B121","doi-asserted-by":"publisher","first-page":"20420188211049614","DOI":"10.1177\/20420188211049614","article-title":"Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus","volume":"12","author":"Zhang","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.cmet.2022.07.010","article-title":"Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment","volume":"34","author":"Zhang","year":"2022","journal-title":"Cell Metab."},{"key":"B123","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/1389201023666220506105026","article-title":"The role of VEGF family in lipid metabolism","volume":"24","author":"Zhou","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"173350","DOI":"10.1016\/j.ejphar.2020.173350","article-title":"Neuregulin 4 alleviates hepatic steatosis via activating AMPK\/mTOR-mediated autophagy in aged mice fed a high fat diet","volume":"884","author":"Zhu","year":"2020","journal-title":"Eur. J. Pharmacol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.1106380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:31:55Z","timestamp":1673382715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.1106380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":124,"alternative-id":["10.3389\/fphys.2022.1106380"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.1106380","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1106380"}}